Vir Biotechnology, Inc. lobbies on its own behalf. For Q4 2023 it reported $70K across 1 client report and lists 1 lobbyist across its filings. Issues include Health Issues, Medicare/Medicaid, Science/Technology and Taxation/Internal Revenue Code.
| Client | Reported | Issues |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | $70K | Health Issues, Medicare/Medicaid, Science/Technology |
| Year | Reported | Clients |
|---|---|---|
| 2023 | $510K | 1 |
| 2022 | $600K | 1 |
| 2021 | $290K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.